General Information of the Compound
Compound ID |
CP0536351
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-[[2-[4-benzyl-4-(dimethylamino)piperidin-1-yl]-4-(trifluoromethyl)phenyl]methyl]-2-[3-fluoro-4-(methanesulfonamido)phenyl]propanamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C32H38F4N4O3S
|
||||||||||||||||||
Molecular Weight |
634.74
|
||||||||||||||||||
Canonical SMILES |
CC(C(=O)NCc1ccc(cc1N1CCC(Cc2ccccc2)(CC1)N(C)C)C(F)(F)F)c1ccc(NS(C)(=O)=O)c(F)c1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C32H38F4N4O3S/c1-22(24-11-13-28(27(33)18-24)38-44(4,42)43)30(41)37-21-25-10-12-26(32(34,35)36)19-29(25)40-16-14-31(15-17-40,39(2)3)20-23-8-6-5-7-9-23/h5-13,18-19,22,38H,14-17,20-21H2,1-4H3,(H,37,41)
Show/Hide
|
||||||||||||||||||
InChIKey |
PDAXSLZUMLDCAK-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01515, Mu-type opioid receptor
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1